
Denovo Biopharma
索元生物
Denovo Biopharma
Biotech/Healthcare
Suzhou (Denovo) Biopharma is a precision medicine company developing Class 1 new drugs, with its clinical center in Beijing and a wholly-owned subsidiary in San Diego, California, USA. Its model is to in-license late-stage clinically validated drugs from major international pharmaceutical…
Latest round: Series D (2020)
Source: ChinaBulls — chinabulls.com
Last updated 2020-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.